Oxford Finance Delivers $125MM Credit Facility to Kala Pharmaceuticals
Oxford Finance closed a $125 million senior secured term loan with Kala Pharmaceuticals, a biopharmaceutical company focused on the discovery, development and commercialization of therapies for eye diseases.
May 13, 2021
Christopher A. Herr | Kala Pharmaceuticals | Oxford Finance
Phil Neuffer